- Home
- BLFS vs ELME Comparison
BLFS vs ELME Comparison
Compare BLFS & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- ELME
- Stock Information
- Founded
- BLFS 1987
- ELME 1960
- Country
- BLFS United States
- ELME United States
- Employees
- BLFS N/A
- ELME N/A
- Industry
- BLFS Medical/Dental Instruments
- ELME Real Estate Investment Trusts
- Sector
- BLFS Health Care
- ELME Real Estate
- Exchange
- BLFS Nasdaq
- ELME Nasdaq
- Market Cap
- BLFS 1.3B
- ELME 1.5B
- IPO Year
- BLFS 1989
- ELME N/A
- Fundamental
- Price
- BLFS $27.98
- ELME $16.53
- Analyst Decision
- BLFS Strong Buy
- ELME Hold
- Analyst Count
- BLFS 7
- ELME 5
- Target Price
- BLFS $30.86
- ELME $15.00
- AVG Volume (30 Days)
- BLFS 366.2K
- ELME 986.4K
- Earning Date
- BLFS 11-06-2025
- ELME 10-23-2025
- Dividend Yield
- BLFS N/A
- ELME 4.36%
- EPS Growth
- BLFS N/A
- ELME N/A
- EPS
- BLFS N/A
- ELME N/A
- Revenue
- BLFS $93,468,000.00
- ELME $246,959,000.00
- Revenue This Year
- BLFS $25.65
- ELME N/A
- Revenue Next Year
- BLFS $14.81
- ELME N/A
- P/E Ratio
- BLFS N/A
- ELME N/A
- Revenue Growth
- BLFS 68.16
- ELME 3.10
- 52 Week Low
- BLFS $19.10
- ELME $13.95
- 52 Week High
- BLFS $29.62
- ELME $18.08
- Technical
- Relative Strength Index (RSI)
- BLFS 57.01
- ELME 40.17
- Support Level
- BLFS $26.74
- ELME $16.46
- Resistance Level
- BLFS $29.57
- ELME $16.94
- Average True Range (ATR)
- BLFS 1.03
- ELME 0.15
- MACD
- BLFS 0.00
- ELME -0.02
- Stochastic Oscillator
- BLFS 55.34
- ELME 14.29
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.